{"schema_version": 1, "id": "tyler-tx-msa/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 337, "label": "Tyler, TX MSA", "slug": "tyler-tx-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:50:44.969897+00:00", "headline": "Tyler's life sci pay splits sharply along credential lines.", "headline_summary": "Biostatistician pay in Tyler ($139,166) now exceeds the national median while Clinical Research Associate pay lags it by 34% ($59,497 vs. $90,065), exposing where local scarcity bites hardest.", "key_indicators": [{"label": "Tyler MSA unemployment rate", "value": "4.0%", "context": "vs 4.4% Texas, 4.2% U.S. (Sept 2026)"}, {"label": "CRA pay gap, metro vs national", "value": "34%", "context": "$59,497 metro vs $90,065 national median"}, {"label": "Texas biopharma job postings growth", "value": "+53% YoY", "context": "Jan\u2013Aug 2026, outpacing hiring capacity"}, {"label": "National biopharma quit rate", "value": "1.9%", "context": "Low turnover keeps experienced talent in place"}], "takeaways": [{"headline": "Clinical Research Associate pay gap in Tyler looks structural.", "body": "Metro CRA advertised pay sits at $59,497 against a national median of $90,065 \u2014 a 34% gap that has persisted while national CRA demand stays candidate-driven. Organizations building out clinical operations locally may need to budget above metro norms or lean further into CRO partnerships for monitoring work."}, {"headline": "Biostatistician pay outpacing national median signals a local specialization premium.", "body": "Tyler's $139,166 median exceeds the national figure of $131,958, an unusual local premium for a credential-driven analytical role. This may indicate a small, concentrated employer base competing hard for a narrow talent pool."}, {"headline": "Regulatory affairs pay softness deserves scrutiny before reading it as reduced demand.", "body": "Advertised pay for Regulatory Affairs Specialists fell moderately both in Tyler and nationally even as industry-wide reporting names regulatory talent among the hardest roles to fill in 2026. Falling advertised pay alongside persistent scarcity may reflect fewer postings even as competition for experienced regulatory professionals holds steady."}, {"headline": "Validation Engineer gains track broader manufacturing investment.", "body": "Metro Validation Engineer pay rose moderately to $104,143, consistent with national reports of sustained biologics manufacturing investment driving bioprocess and automation hiring. Quality and manufacturing leaders should expect this premium to hold as CDMOs compete for the same credential pool."}], "local_conditions": "Tyler MSA unemployment eased to 4.0% in September, below both the Texas rate of 4.4% and tracking a metro labor force that contracted slightly month-over-month (-1,000) while still up 900 jobs year-over-year. Life sciences hiring demand in the metro is colliding with a thin specialist pool, consistent with statewide dynamics where Texas biopharma job postings rose 53% year-over-year against limited R&D and quality headcount growth.", "implications": "Local wage stability in Clinical Data Manager and Lab Technician roles contrasts with sharp divergence in Research Scientist and Biostatistician pay, suggesting employers are concentrating compensation increases on roles tied to late-stage asset work. Regulatory Affairs Specialist advertised pay fell moderately both locally ($95,473) and nationally ($103,780) even as national commentary flags regulatory talent as among the hardest roles to fill \u2014 a gap that may reflect fewer open requisitions alongside steady demand for the skill set. Consider reviewing whether regulatory affairs compensation has drifted below the level needed to retain credentialed talent against CRO and CDMO competitors still bidding aggressively for CMC and biomanufacturing expertise.", "looking_ahead": [{"category": "Worth watching", "body": "Tyler's labor force dipped by 1,000 in September after months of modest growth \u2014 watch whether this reflects normal volatility or an early signal of tightening local supply for specialized science and quality roles."}, {"category": "Emerging pressure point", "body": "National CRA demand remains candidate-driven with employers holding or modestly growing headcount through 2026. A persistent 34% local-to-national pay gap in Tyler may make it harder to recruit experienced CRAs without relocation incentives or hybrid structures."}, {"category": "Potential inflection point", "body": "Texas biopharma postings grew 53% year-over-year while quality discipline postings fell 17% nationally \u2014 a mismatch that could push more quality and compliance work toward CDMO and CRO partners if local hiring capacity doesn't catch up."}, {"category": "Expected", "body": "Texas service-sector wage pressure hit its highest reading since January 2023 in October's Dallas Fed survey. Expect continued upward pressure on total rewards packages for roles competing against broader service-sector wage gains across life sciences and other industries alike."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 82764.5, "metro_p50": 123070.0, "metro_p75": 131979.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 56451.0, "metro_p50": 59497.0, "metro_p75": 66151.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "state_rollup", "metro_p25": 38082.0, "metro_p50": 45670.0, "metro_p75": 49587.5, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "state_rollup", "metro_p25": 70793.0, "metro_p50": 95472.6, "metro_p75": 116373.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 96453.0, "metro_p50": 122953.0, "metro_p75": 135700.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 98484.75, "metro_p50": 139166.0, "metro_p75": 160691.25, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 82756.0, "metro_p50": 104143.2, "metro_p75": 112977.0, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Texas Workforce Commission", "source_url": null, "statement": "Tyler MSA unemployment rate was 4.0% in September 2026"}, {"source_name": "Life sciences labor market research notes", "source_url": null, "statement": "Texas biopharma job postings surged 53% YoY Jan\u2013Aug 2026"}, {"source_name": "Biopharma industry hiring survey", "source_url": null, "statement": "Regulatory affairs named among hardest pharma roles to fill in 2026"}, {"source_name": "Life sciences labor market research notes", "source_url": null, "statement": "National CRA demand remains candidate-driven with scarce experienced talent"}, {"source_name": "Dallas Federal Reserve Service Sector Survey", "source_url": null, "statement": "Texas service sector wages/benefits index hit highest since January 2023"}, {"source_name": "Life sciences labor market research notes", "source_url": null, "statement": "National biopharma quit rate sits at 1.9%"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "tyler-tx-msa/life-sciences/2026-10.html", "pdf": "tyler-tx-msa/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:31:38.492964+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/tyler-tx-msa/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/tyler-tx-msa/life-sciences/2026-10.pdf"}